Provided by Tiger Trade Technology Pte. Ltd.

Aethlon Medical

6.63
+0.11001.69%
Post-market: 6.59-0.0400-0.60%18:31 EDT
Volume:64.16K
Turnover:420.97K
Market Cap:10.64M
PE:-0.16
High:6.66
Open:6.51
Low:6.26
Close:6.52
52wk High:41.35
52wk Low:1.41
Shares:1.60M
Float Shares:1.60M
Volume Ratio:0.53
T/O Rate:4.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-42.4608
EPS(LYR):-428.8747
ROE:-160.91%
ROA:-76.69%
PB:2.05
PE(LYR):-0.02

Loading ...

Aethlon Medical Shareholders Expand Capital Structure Flexibility

TIPRANKS
·
55 mins ago

Aethlon Medical Holds Annual Shareholder Meeting

Reuters
·
1 hour ago

Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)

TIPRANKS
·
Sep 24

Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall

Benzinga Earnings
·
Sep 17

Aethlon Medical Announces Merger with North Immunology

TIPRANKS
·
Sep 17

M&A News: Aethlon Medical Stock (AEMD) Rockets 400% After North Immunology Deal to Fight Eczema

TIPRANKS
·
Sep 17

U.S. Stocks on the MOVE-Generac, Jefferies, Aethlon Medical

Reuters
·
Sep 17

Aethlon Medical, North Immunology enter all-stock transaction

TIPRANKS
·
Sep 17

Aethlon Medical Shares Jump 87.4% to $2.68 Premarket After Co Enters Merger Agreement with North Immunology

THOMSON REUTERS
·
Sep 17

Aethlon Medical Agrees All-Stock Merger with North Immunology

Reuters
·
Sep 17

Aethlon Medical: Pre-Merger Aethlon Stockholders to Own About 4.75%, North Immunology Stockholders to Own About 95.25% of Combined Co

THOMSON REUTERS
·
Sep 17

Aethlon Medical - Enters Definitive All-Stock Merger Agreement with North Immunology

THOMSON REUTERS
·
Sep 17

Aethlon Medical - Combined Company Expected to Have Pro Forma Equity Value of $346.50 Mln

THOMSON REUTERS
·
Sep 17

Aethlon Medical Inc - Pre-Merger North Immunology Stockholders Expected to Own Approximately 95.25% of Combined Company

THOMSON REUTERS
·
Sep 17

Aethlon Medical - $180 Mln Private Placement Expected to Fund Operations into Second Half of 2028

THOMSON REUTERS
·
Sep 17

Aethlon Medical & North Immunology Announce Merger to Advance Novel Il-13 X Il-18 Bispecific Antibody for Atopic Dermatitis

THOMSON REUTERS
·
Sep 17

Aethlon Medical - Stockholders to Receive Contingent Value Right for Each Share Held

THOMSON REUTERS
·
Sep 17

Aethlon Medical - Combined Entity to Operate as North Immunology, and Trade Under Ticker Nrtx

THOMSON REUTERS
·
Sep 17

Aethlon Medical Amends CEO, CFO and CMO Deals to Pay Change-in-Control Severance in Lump Sum

Reuters
·
Sep 15

Aethlon Medical Announces Annual Shareholder Meeting

Reuters
·
Sep 01